SG Americas Securities’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,242
| Closed | -$217K | – | 2557 |
|
|
2025
Q1 | $217K | Sell |
25,242
-9,602
| -28% | -$82.5K | ﹤0.01% | 2210 |
|
|
2024
Q4 | $374K | Buy |
34,844
+7,138
| +26% | +$76.6K | ﹤0.01% | 1406 |
|
|
2024
Q3 | $157K | Buy |
27,706
+14,272
| +106% | +$80.9K | ﹤0.01% | 2383 |
|
|
2024
Q2 | $57K | Buy |
+13,434
| New | +$57K | ﹤0.01% | 2303 |
|
|
2024
Q1 | – | Sell |
-307,568
| Closed | -$2.86M | – | 2571 |
|
|
2023
Q4 | $2.86M | Buy |
307,568
+38,155
| +14% | +$355K | 0.03% | 465 |
|
|
2023
Q3 | $1.77M | Buy |
+269,413
| New | +$1.77M | 0.02% | 760 |
|
|
2023
Q2 | – | Sell |
-31,382
| Closed | -$269K | – | 1987 |
|
|
2023
Q1 | $269K | Buy |
31,382
+14,309
| +84% | +$123K | ﹤0.01% | 2007 |
|
|
2022
Q4 | $158K | Buy |
17,073
+2,615
| +18% | +$24.2K | ﹤0.01% | 2161 |
|
|
2022
Q3 | $149K | Sell |
14,458
-19,036
| -57% | -$196K | ﹤0.01% | 2278 |
|
|
2022
Q2 | $335K | Buy |
+33,494
| New | +$335K | ﹤0.01% | 2098 |
|
|
2022
Q1 | – | Sell |
-12,550
| Closed | -$218K | – | 2589 |
|
|
2021
Q4 | $218K | Sell |
12,550
-12,656
| -50% | -$220K | ﹤0.01% | 2371 |
|
|
2021
Q3 | $452K | Buy |
+25,206
| New | +$452K | ﹤0.01% | 2389 |
|
|
2021
Q2 | – | Sell |
-10,419
| Closed | -$156K | – | 2509 |
|
|
2021
Q1 | $156K | Buy |
+10,419
| New | +$156K | ﹤0.01% | 2582 |
|
|
2018
Q1 | – | Sell |
-21,389
| Closed | -$69K | – | 2667 |
|
|
2017
Q4 | $69K | Buy |
+21,389
| New | +$69K | ﹤0.01% | 2447 |
|
|
2016
Q2 | – | Sell |
-12,700
| Closed | -$62K | – | 2127 |
|
|
2016
Q1 | $62K | Buy |
+12,700
| New | +$62K | ﹤0.01% | 2388 |
|